ALK expression was found to be significantly associated with poorly differentiated tumor (p = 0.0039), infiltrating ductal carcinoma subtype (p = 0.0076) and triple-negative breast cancer (p = 0.0034); however, no association was seen with age, lymph node involvement, distant metastasis and tumor stage. This evidence concerns the gene ALK and invasive ductal breast carcinoma.